De Novo Variants Disturbing the Transactivation Capacity of POU3F3 Cause a Characteristic Neurodevelopmental Disorder.

[1]  G. Vriend,et al.  MetaDome: Pathogenicity analysis of genetic variants through aggregation of homologous human protein domains , 2019, bioRxiv.

[2]  Damian Smedley,et al.  matchbox: An open‐source tool for patient matching via the Matchmaker Exchange , 2018, Human mutation.

[3]  S. Pro,et al.  Mutations in KCNK4 that Affect Gating Cause a Recognizable Neurodevelopmental Syndrome. , 2018, American journal of human genetics.

[4]  T. Meitinger,et al.  A De Novo Missense Variant in POU3F2 Identified in a Child with Global Developmental Delay , 2018, Neuropediatrics.

[5]  Q. Waisfisz,et al.  Homozygous DMRT2 variant associates with severe rib malformations in a newborn , 2018, American journal of medical genetics. Part A.

[6]  N. Matsumoto,et al.  A homozygous NOP14 variant is likely to cause recurrent pregnancy loss , 2018, Journal of Human Genetics.

[7]  Jeffrey Pennington,et al.  Novel findings with reassessment of exome data: implications for validation testing and interpretation of genomic data , 2018, Genetics in Medicine.

[8]  Simon E Fisher,et al.  Speech and Language: Translating the Genome. , 2017, Trends in genetics : TIG.

[9]  K. Helbig,et al.  Classification of Genes: Standardized Clinical Validity Assessment of Gene–Disease Associations Aids Diagnostic Exome Analysis and Reclassifications , 2017, Human mutation.

[10]  Carol J. Saunders,et al.  Biallelic Mutations in TBCD, Encoding the Tubulin Folding Cofactor D, Perturb Microtubule Dynamics and Cause Early-Onset Encephalopathy. , 2016, American journal of human genetics.

[11]  L. Vissers,et al.  Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability , 2016, Nature Neuroscience.

[12]  J. Rivière,et al.  Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole‐exome sequencing as a first‐line diagnostic test , 2016, Clinical genetics.

[13]  Philippe M Campeau,et al.  Small 6q16.1 Deletions Encompassing POU3F2 Cause Susceptibility to Obesity and Variable Developmental Delay with Intellectual Disability. , 2016, American journal of human genetics.

[14]  James Y. Zou.  Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[15]  D. Valle,et al.  GeneMatcher: A Matching Tool for Connecting Investigators with an Interest in the Same Gene , 2015, Human mutation.

[16]  R. Pfundt,et al.  De Novo Mutations in CHAMP1 Cause Intellectual Disability with Severe Speech Impairment. , 2015, American journal of human genetics.

[17]  Tomas W. Fitzgerald,et al.  Large-scale discovery of novel genetic causes of developmental disorders , 2014, Nature.

[18]  Xiang Li,et al.  Enhanced utility of family-centered diagnostic exome sequencing with inheritance model–based analysis: results from 500 unselected families with undiagnosed genetic conditions , 2014, Genetics in Medicine.

[19]  P. Deriziotis,et al.  Investigating protein-protein interactions in live cells using bioluminescence resonance energy transfer. , 2014, Journal of visualized experiments : JoVE.

[20]  B. Menten,et al.  A de novo POU3F3 Deletion in a Boy with Intellectual Disability and Dysmorphic Features , 2013, Molecular Syndromology.

[21]  Pasko Rakic,et al.  POU-III transcription factors (Brn1, Brn2, and Oct6) influence neurogenesis, molecular identity, and migratory destination of upper-layer cells of the cerebral cortex. , 2013, Cerebral cortex.

[22]  H. Burbano,et al.  A recent evolutionary change affects a regulatory element in the human FOXP2 gene. , 2013, Molecular biology and evolution.

[23]  P. Kolatkar,et al.  Crystal structure of the dimeric Oct6 (POU3f1) POU domain bound to palindromic MORE DNA , 2010, Proteins.

[24]  M. Tomita,et al.  Systematic identification of cell cycle-dependent yeast nucleocytoplasmic shuttling proteins by prediction of composite motifs , 2009, Proceedings of the National Academy of Sciences.

[25]  Manuel Corpas,et al.  DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. , 2009, American journal of human genetics.

[26]  D. Cane,et al.  The nonsense-mediated decay RNA surveillance pathway. , 2007, Annual review of biochemistry.

[27]  L. Nguyen,et al.  Proneural bHLH and Brn proteins coregulate a neurogenic program through cooperative binding to a conserved DNA motif. , 2006, Developmental cell.

[28]  N. Saitou,et al.  Class III POU genes: Generation of homopolymeric amino acid repeats under GC pressure in mammals , 1996, Journal of Molecular Evolution.

[29]  M. Hentze,et al.  Nonsense-mediated decay approaches the clinic , 2004, Nature Genetics.

[30]  H. Schöler,et al.  Differential activity by DNA-induced quarternary structures of POU transcription factors. , 2002, Biochemical pharmacology.

[31]  Tetsuo Noda,et al.  Brn-1 and Brn-2 share crucial roles in the production and positioning of mouse neocortical neurons. , 2002, Genes & development.

[32]  Gert Vriend,et al.  Increasing the precision of comparative models with YASARA NOVA—a self‐parameterizing force field , 2002, Proteins.

[33]  M. Rosenfeld,et al.  Transcriptional Regulation of Cortical Neuron Migration by POU Domain Factors , 2002, Science.

[34]  A. Monaco,et al.  A forkhead-domain gene is mutated in a severe speech and language disorder , 2001, Nature.

[35]  P. Parsons,et al.  Domains of Brn-2 that mediate homodimerization and interaction with general and melanocytic transcription factors. , 2000, European journal of biochemistry.

[36]  B. Luisi,et al.  The virtuoso of versatility: POU proteins that flex to fit. , 2000, Journal of molecular biology.

[37]  E. Turner,et al.  Highly Cooperative Homodimerization Is a Conserved Property of Neural POU Proteins* , 1998, The Journal of Biological Chemistry.

[38]  M. Ichikawa,et al.  Predominant expression of Brn-2 in the postmitotic neurons of the developing mouse neocortex , 1997, Brain Research.

[39]  J. Manfredi,et al.  Spacing and orientation of bipartite DNA-binding motifs as potential functional determinants for POU domain factors. , 1993, Genes & development.

[40]  G Vriend,et al.  WHAT IF: a molecular modeling and drug design program. , 1990, Journal of molecular graphics.

[41]  R. Tjian,et al.  Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. , 1989, Science.

[42]  L. Swanson,et al.  Expression of a large family of POU-domain regulatory genes in mammalian brain development , 1989, Nature.